Form 4: Eli Lilly Officer Gifts Shares Under 10b5-1 Plan

Eli Lilly's EVP, Chief People Officer, Eric Dozier, reported a gift of 481 common shares under a pre-arranged 10b5-1 plan.

Summary

• Eric Dozier, Executive Vice President and Chief People Officer of Eli Lilly & Co. (LLY), reported a transaction involving the company's common stock.
• The transaction, dated February 19, 2026, was a disposition of 481 shares of common stock.
• The transaction type was a gift, indicated by Transaction Code 'G', with a price of $0 per share.
• Following this transaction, Eric Dozier directly beneficially owns 14,455.212 shares of common stock.
• Additionally, Eric Dozier indirectly beneficially owns 385.02 shares through a 401(k) plan.
• The transaction was made pursuant to a contract, instruction, or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. A gift of shares under a 10b5-1 plan is typically a pre-planned personal financial action and not a direct reflection of the company's operational performance or future prospects.

Positives

• The transaction is a gift, not a sale for cash, which typically does not signal a lack of confidence in the company's future prospects.
• The transaction was executed under a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on recent, non-public information.

Negatives

• The direct beneficial ownership of common stock by a key executive has decreased by 481 shares.

Future Outlook

This filing, a Form 4, does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

StockSavvy.ai notes that insider transactions, particularly gifts executed under a Rule 10b5-1 plan, are common practices for executives. These transactions are typically pre-arranged for personal financial planning, estate management, or charitable giving, and are generally not indicative of immediate shifts in company performance or broader industry trends.

Comparison to Industry Standards

• Insider gifting is a standard practice for executives across various industries, including pharmaceuticals. For example, executives at peer companies such as Pfizer (PFE) or Johnson & Johnson (JNJ) also engage in similar gifting activities as part of their personal financial planning or charitable endeavors.
• The use of a 10b5-1 plan for such transactions is a common compliance measure, ensuring that the transaction is pre-scheduled and not based on material non-public information, a practice widely adopted by corporate insiders to mitigate regulatory risk.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine insider transaction and not an operational or strategic announcement.
• Employees, Customers, Suppliers, Creditors: No direct impact from this insider transaction.

Key Dates

Recommendation

This Form 4 filing reports a routine insider transaction (a gift of shares under a 10b5-1 plan) by an executive. It does not contain any information related to the company's financial performance, strategic direction, or operational health that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as there's no new fundamental information to alter an existing investment thesis.

Keywords

Eli Lilly, LLY, Eric Dozier, Insider Transaction, Form 4, Common Stock, 10b5-1 Plan, Gift, Officer